Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-13 7:21 pm Purchase | 2024-05-09 | 13D | T2 Biosystems, Inc. TTOO | CR Group L.P. | 10,677,973 69.500% | 1,824,800 (+20.61%) | Filing History |
| 2024-05-07 7:46 pm Purchase | 2024-05-03 | 13D | T2 Biosystems, Inc. TTOO | CR Group L.P. | 8,853,173 65.400% | 4,748,335 (+115.68%) | Filing History |
| 2024-04-19 4:31 pm Purchase | 2024-04-12 | 13D | T2 Biosystems, Inc. TTOO | CR Group L.P. | 4,104,838 46.680% | 4,104,838 (New Position) | Filing History |
| 2024-03-15 5:00 pm Purchase | 2024-03-07 | 13G | Avinger, Inc. AVGR | CR Group L.P. | 150,545 9.900% | 150,545 (New Position) | Filing History |
| 2023-08-14 3:22 pm Purchase | 2023-08-04 | 13G | Avinger, Inc. AVGR | CR Group L.P. | 178,944 19.900% | 178,944 (New Position) | Filing History |
| 2023-07-13 3:58 pm Purchase | 2023-07-03 | 13G | T2 Biosystems, Inc. TTOO | CR Group L.P. | 725,036 19.900% | 725,036 (New Position) | Filing History |
| 2021-01-06 4:15 pm Sale | 2020-12-31 | 13G | Assertio Holdings, Inc. ASRT | CR Group L.P. | 72,787 0.300% | -1,500,000 (-95.37%) | Filing History |
| 2020-12-30 4:19 pm Sale | 2020-12-23 | 13G | Assertio Holdings, Inc. ASRT | CR Group L.P. | 1,572,787 5.600% | -2,816,796 (-64.17%) | Filing History |
| 2020-06-09 12:04 pm Unchanged | 2020-05-11 | 13D | TEARLAB CORP TEAR | CR Group L.P. | 11,850,131 48.500% | 0 (Unchanged) | Filing History |
| 2020-05-28 4:05 pm Purchase | 2020-05-20 | 13G | Assertio Holdings, Inc. ASRT | CR Group L.P. | 4,389,583 15.800% | 4,389,583 (New Position) | Filing History |
| 2020-05-22 4:07 pm Sale | 2020-05-20 | 13D | EGALET CORP COM PAR $0.001 ZCOR | CR Group L.P. | 0 0.000% | -7,023,333 (Position Closed) | Filing History |
| 2020-05-21 12:01 pm Purchase | 2020-05-11 | 13D | TEARLAB CORP TEAR | CR Group L.P. | 11,850,131 48.500% | 11,850,131 (New Position) | Filing History |
| 2020-03-25 8:53 pm Unchanged | 2020-03-16 | 13D | EGALET CORP COM PAR $0.001 ZCOR | CR Group L.P. | 7,023,333 58.700% | 0 (Unchanged) | Filing History |
| 2020-02-13 3:42 pm Purchase | 2019-11-26 | 13G | Viveve Medical, Inc. VIVE | CR Group L.P. | 698,647 67.200% | 698,647 (New Position) | Filing History |
| 2020-02-13 3:39 pm Purchase | 2018-02-24 | 13G | Avinger, Inc. AVGR | CR Group L.P. | 6,970 16.800% | 6,970 (New Position) | Filing History |